Incidence of post pancreatectomy acute pancreatitis after pancreaticodeodenctomy
Not Applicable
- Conditions
- Health Condition 1: C259- Malignant neoplasm of pancreas, unspecified
- Registration Number
- CTRI/2023/02/050147
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients scheduled to receive elective pancreaticoduodenectomy (PD - Kausch-Whipple or LongmireTraverso) for all type of pancreatic disease (benign, malignant, or premalignant) will be enrolled.
In order to be eligible to participate in this study, a patient must meet all of the following criteria:
-Scheduled for elective PD
-Upfront or after neoadjuvant therapy surgery is allowed
-The ability of the subject to understand the character and individual consequences of the clinical trial
-Written informed consent
Exclusion Criteria
-Patients undergoing emergency surgery
-Informed consent withdrawal
-Inability to perform the resection for any reason;Total or distal pancreatectomy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method